TriangleNCT00072475 · OUTCOME
Overall Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Duration of study (up to 5 years)
What was measured
Overall survival (OS) as the interval from the on-study date until death. OS was estimated using the Kaplan Meier method.
Groups in this outcome
Vatalanib
Adult patients with MDS receive treatment with vatalanib. vatalanib: Pts registered before 1/15/05 1250 mg/day PO After 1/15/05: Start w/ 750 mg/day PO; escalate q 4 wks in absence of Grade 2 or \> tox (1st increase=1000mg/day; 2nd increase 1250 mg/day)
| Group | Source count |
|---|---|
| Vatalanib | 142 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Vatalanib | 18.9 | Not reported | 15.0 | 26.8 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 15.0
- upper Limit
- 26.8
- value
- 18.9
- denoms
- counts
- group Id
- OG000
- value
- 142
- units
- Participants
- description
- Overall survival (OS) as the interval from the on-study date until death. OS was estimated using the Kaplan Meier method.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Adult patients with MDS receive treatment with vatalanib. vatalanib: Pts registered before 1/15/05 1250 mg/day PO After 1/15/05: Start w/ 750 mg/day PO; escalate q 4 wks in absence of Grade 2 or \> tox (1st increase=1000mg/day; 2nd increase 1250 mg/day)
- id
- OG000
- title
- Vatalanib
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- Duration of study (up to 5 years)
- title
- Overall Survival
- type
- SECONDARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice